Mutagenesis of the central hydrophobic cluster in Aβ42 Alzheimer's pepticle -: Side-chain properties correlate with aggregation propensities

被引:137
作者
de Groot, NS
Aviles, FX
Vendrell, J
Ventura, S [1 ]
机构
[1] Univ Autonoma Barcelona, Dept Bioquim & Biol Mol, E-08193 Bellaterra, Spain
[2] Univ Autonoma Barcelona, Inst Biotecnol & Biomed, E-08193 Bellaterra, Spain
关键词
protein aggregation; protein misfolding; Alzheimer's disease; green fluorescent protein; Escherichia coli;
D O I
10.1111/j.1742-4658.2005.05102.x
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Protein misfolding and deposition underlie an increasing number of debilitating human disorders. Alzheimer's disease is pathologically characterized by the presence of numerous insoluble amyloid plaques in the brain, composed primarily of the 42 amino acid human beta-amyloid peptide (A beta 42). Disease-linked mutations in A beta 42 occur in or near a central hydrophobic cluster comprising residues 17-21. We exploited the ability of green fluorescent protein to act as a reporter of the aggregation of upstream fused A beta 42 variants to characterize the effects of a large set of single-point mutations at the central position of this hydrophobic sequence as well as substitutions linked to early onset of the disease located in or close to this region. The aggregational properties of the different protein variants clearly correlated with changes in the intrinsic physicochemical properties of the side chains at the point of mutation. Reduction in hydrophobicity and beta-shcet propensity resulted in an increase of in vivo fluorescence indicating disruption of aggregation, as confirmed by the in vitro analysis of synthetic A beta 42 variants. The results confirm the key role played by the central hydrophobic stretch on A beta 42 deposition and support the hypothesis that sequence tunes the aggregation propensities of polypeptides.
引用
收藏
页码:658 / 668
页数:11
相关论文
共 55 条
[1]   Amyloid fibril formation by Aβ16-22, a seven-residue fragment of the Alzheimer's β-amyloid peptide, and structural characterization by solid state NMR [J].
Balbach, JJ ;
Ishii, Y ;
Antzutkin, ON ;
Leapman, RD ;
Rizzo, NW ;
Dyda, F ;
Reed, J ;
Tycko, R .
BIOCHEMISTRY, 2000, 39 (45) :13748-13759
[2]   Mechanism of inactivation on prion conversion of the Saccharomyces cerevisiae Ure2 protein [J].
Baxa, U ;
Speransky, V ;
Steven, AC ;
Wickner, RB .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2002, 99 (08) :5253-5260
[3]   Amyloid β-protein:: Monomer structure and early aggregation states of Aβ42 and its Pro19 alloform [J].
Bernstein, SL ;
Wyttenbach, T ;
Baumketner, A ;
Shea, JE ;
Bitan, G ;
Teplow, DB ;
Bowers, MT .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 2005, 127 (07) :2075-2084
[4]   Elucidation of primary structure elements controlling early amyloid β-protein oligomerization [J].
Bitan, G ;
Vollers, SS ;
Teplow, DB .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (37) :34882-34889
[5]   Familial Alzheimer's disease-linked presenilin 1 variants elevate A beta 1-42/1-40 ratio in vitro and in vivo [J].
Borchelt, DR ;
Thinakaran, G ;
Eckman, CB ;
Lee, MK ;
Davenport, F ;
Ratovitsky, T ;
Prada, CM ;
Kim, G ;
Seekins, S ;
Yager, D ;
Slunt, HH ;
Wang, R ;
Seeger, M ;
Levey, AI ;
Gandy, SE ;
Copeland, NG ;
Jenkins, NA ;
Price, DL ;
Younkin, SG .
NEURON, 1996, 17 (05) :1005-1013
[6]   Inherent toxicity of aggregates implies a common mechanism for protein misfolding diseases [J].
Bucciantini, M ;
Giannoni, E ;
Chiti, F ;
Baroni, F ;
Formigli, L ;
Zurdo, JS ;
Taddei, N ;
Ramponi, G ;
Dobson, CM ;
Stefani, M .
NATURE, 2002, 416 (6880) :507-511
[7]   Amyloid-like properties of bacterial inclusion bodies [J].
Carrió, M ;
González-Montalbán, N ;
Vera, A ;
Villaverde, A ;
Ventura, S .
JOURNAL OF MOLECULAR BIOLOGY, 2005, 347 (05) :1025-1037
[8]   Rationalization of the effects of mutations on peptide and protein aggregation rates [J].
Chiti, F ;
Stefani, M ;
Taddei, N ;
Ramponi, G ;
Dobson, CM .
NATURE, 2003, 424 (6950) :805-808
[9]   Studies of the aggregation of mutant proteins in vitro provide insights into the genetics of amyloid diseases [J].
Chiti, F ;
Calamai, M ;
Taddei, N ;
Stefani, M ;
Ramponi, G ;
Dobson, CM .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2002, 99 :16419-16426
[10]   Therapeutic approaches to protein-misfolding diseases [J].
Cohen, FE ;
Kelly, JW .
NATURE, 2003, 426 (6968) :905-909